Genetic testing helps predict disease recurrence in myelodysplastic syndrome
(Washington University School of Medicine) A DNA-based analysis of blood cells soon after a stem cell transplant can predict likelihood of disease recurrence in patients with myelodysplastic syndrome (MDS), a group of cancerous disorders characterized by dysfunctional blood cells, according to new research at Washington University School of Medicine in St. Louis. Such a practice could help doctors identify patients at high risk of disease recurrence early after a transplant and help guide treatment decisions.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Genetics | Myelodysplastic Syndrome | Stem Cell Therapy | Stem Cells | Transplants | Washington University